ARS Pharmaceuticals, Inc. - SPRY
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 02, 2026 | President | A | A | 898,456.0 | 0.0 | 0.0 | 898,456.0 | View | |
| Jun 26, 2026 | — | A | A | 30,000.0 | 0.0 | 0.0 | 30,000.0 | View | |
| Jun 26, 2026 | — | A | A | 30,000.0 | 0.0 | 0.0 | 30,000.0 | View | |
| Jun 26, 2026 | — | A | A | 30,000.0 | 0.0 | 0.0 | 30,000.0 | View | |
| Jun 26, 2026 | — | A | A | 30,000.0 | 0.0 | 0.0 | 30,000.0 | View | |
| Jun 26, 2026 | — | A | A | 30,000.0 | 0.0 | 0.0 | 30,000.0 | View | |
| Jun 26, 2026 | — | A | A | 30,000.0 | 0.0 | 0.0 | 30,000.0 | View | |
| Jun 26, 2026 | — | A | A | 30,000.0 | 0.0 | 0.0 | 30,000.0 | View | |
| Jun 26, 2026 | — | A | A | 30,000.0 | 0.0 | 0.0 | 30,000.0 | View | |
| Jun 26, 2026 | — | A | A | 30,000.0 | 0.0 | 0.0 | 30,000.0 | View | |
| Jun 12, 2026 | Chief Commercial Officer | M | D | 25,000.0 | 0.0 | 0.0 | 519,588.0 | View | |
| Jun 12, 2026 | Chief Commercial Officer | S | D | 25,000.0 | 10.0 | 250,000.0 | 12,176.0 | View | |
| Jun 12, 2026 | Chief Commercial Officer | M | A | 25,000.0 | 1.5 | 37,500.0 | 37,176.0 | View | |
| Jun 12, 2026 | Chief Legal Officer | S | D | 3,355.0 | 10.0 | 33,550.0 | 90,910.0 | View |